← All tickers

Is CCCC Worth Buying in 2026?

C4 Therapeutics, Inc.

STOCK BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Updated 2026-06-14

Here’s whether C4 Therapeutics, Inc. (CCCC) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.

🟢
Bullish

Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+9.18% over 10 days); RSI 56 — healthy momentum range; strong 1-year return of +140.7%; 3-month momentum positive (+42.9%). Currently 15.2% off its 52-week high. Score: +7/7.

Ready to act on this? 📈 Trade on Webull

CCCC is in a confirmed uptrend, trading above both its 50-day ($3.27) and 200-day ($2.63) moving averages. An RSI of 56.4 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +140.7% compares to +22.9% for SPY (beat the market by 117.9%).

$10,000 invested 1 year ago → $24,074 today
vs. S&P 500 (SPY) — same period beat market by 117.9%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

✓Above 200-day MA ($2.63)
✓Above 50-day MA ($3.27)
✓RSI(14) neutral zone (30–70) — currently 56.4
✓Positive return (+140.7%)
!Within 10% of period high (−15.2%)
Period Range $3.90
$1.36 $4.60
RSI (14) 56.4
0 · OversoldOverbought · 100

Key Metrics

Price$3.90
Period Return+140.7%
Period High$4.60
Period Low$1.36
Drawdown−15.2%
MA-50$3.27
MA-200$2.63
RSI (14)56.4
Avg Volume (30d)2.9M
vs. SPYbeat by 117.9%
Return Rank#138 of 1246

Trade CCCC

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers